SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-026842
Filing Date
2013-05-10
Accepted
2013-05-10 06:06:07
Documents
3
Period of Report
2013-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd379405.html 3  
1 FORM 3 rrd379405.xml 3 5588
2 POWER OF ATTORNEY rrd341017_385468.htm EX-24.1 4082
3 POWER OF ATTORNEY rrd341017_385469.htm EX-24.2 4170
  Complete submission text file 0001181431-13-026842.txt   15914
Mailing Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008
Business Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008 33 1 53 054100
SOFINNOVA CAPITAL VI FCPR (Reporting) CIK: 0001441261 (see all company filings)

State of Incorp.: XX
Type: 3 | Act: 34 | File No.: 001-35905 | Film No.: 13830949

Mailing Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476
Business Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476 612-747-4423
BioAmber Inc. (Issuer) CIK: 0001534287 (see all company filings)

IRS No.: 980601045 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals

Mailing Address 17 RUE DE SERENE PARIS I0 75008
Business Address 17 RUE DE SERENE PARIS I0 75008 33 1 53 05 41 13
Sofinnova Partners SAS (Reporting) CIK: 0001574139 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35905 | Film No.: 13830950